12 p.m.

Registration Desk Open

Co-Chairs’ Welcoming Comments

• Sarah Spencer – Principal, EcoR1
• Tim Watkins, MD, MS – Vice President, Clinical Development; Head – Fibrosis & Pulmonary Diseases - Inflammation Therapeutics, Gilead Sciences

Pioneer Sponsor Address

• Amy Olson, MD, MSPH – Executive Director, Medical Affairs Strategy Team Lead, Boehringer Ingelheim Pharmaceuticals, Inc.
  
  

Patient Groups Panel

• Donna Appell, RN – Founder and Executive Director, Hermansky-Pudlak Syndrome Network
• Michele Manion – Executive Director, PCD Foundation
• Siri Vaeth, MSW – Executive Director, Cystic Fibrosis Research Institute
• Paula Blonski – Founder and President, ARDS Alliance

Panel Discussion: Perspectives on Biomedical Innovation from the Federal Government

• Moderator: Joshua Fessel, MD, PhD, ATSF - Senior Clinical Advisor, Division of Clinical Innovation; National Center for Advancing Translational Sciences (NCATS); NIH
• Steve Flaim, PhD, FACC, FAHA – Senior Special Advisor & Investor-In-Residence, NHLBI, NIH
• Steve Hoffman, MS, BSc - Associate Vice President, Research Partnerships at Foundation for the National Institutes of Health
• Kimberly Armstrong, PhD, MT (ASCP)- Therapeutics Branch Chief, Influenza and Emerging Infectious Diseases Division (IEIDD), BARDA, ASPR, DHHS
• Bhavika Kaul, MD, MS - Physician-Investigator, VA Center for Innovation in Quality, Effectiveness, and Safety
• Rachel Ramoni, DMD, ScD – Chief Research and Development Officer, US Department of Veterans Affairs

Welcome from the ATS President

• M. Patricia Rivera, MD, ATSF- Chief, Division of Pulmonary and Critical Care Medicine, University of Rochester Medical Center

Co-Chair Address: State of Innovation and Investment

• Sarah Spencer – Principal, EcoR1
• Tim Watkins, MD, MS – Vice President, Clinical Development; Head – Fibrosis & Pulmonary Diseases - Inflammation Therapeutics, Gilead Sciences

Showcase One: Asthma and COPD Innovators

• RaeSedo, Inc. – Monica Kraft, MD, Co-Founder
• RAGE Biotech – Gary Anderson, Advisor, Clinical Translation
• Realta LifeSciences – Ulrich Thienel, MD, PhD, CEO
• Shanghi Novamab Biopharmaceuticals Co., LTD – Yakun Wan, PhD, Founder and CEO
• SMS Biotech – Abdulkader Rahmo, PhD – President and CSO

Panel: Investor Discussion

• Moderator: Niall O'Donnell, PhD - Managing Director, Rivervest
• Bernard Davitain, MSc, CPA, MBA – Partner, Omega Funds
• Drew Field – Vice President, Bain Capital Life Sciences
• Katarina Pance, PhD - Associate, SR One Capital Management
• Geeta Vemuri – Managing Partner / Founder, Agent Capital

Showcase Two: COVID, Infectious Disease and Other Innovators

• Cystetic Medicines, Inc. – Martin D. Burke, MD, PhD – Co-Founder
• ENA Respiratory – Ruth Tal-Singer, PhD, Medicine Development Leader
• ReCode Therapeutics – John Matthews, MB, BS, PhD, MCRP – Chief Medical Officer
• RNATICS – Klaus Rabe, MD, Chief Medical Officer
• Vast Therapeutics – Nathan Stasko, PhD, MS, Chief Executive Officer

Fireside Chat: Accelerating Respiratory Discovery

• Moderator: Ted Reiss, MD, MBE, ATSF
• Sally Seymour, MD – Director, Division of Pulmonology, Allergy, and Critical Care, US Food and Drug Administration
• Banu Karimi-Shah, MD – Deputy Director, Division of Pulmonology, Allergy, Critical Care, US Food and Drug Administration

Showcase Three: Critical Care Innovators

• Atelerix Life Sciences – Benjamin Gaston, MD, Founder
• Chrysalis BioTherapeutics, Inc. – Darrell H. Carney, PhD, President and CEO
• Eldec Pharmaceuticals – Saira Ahmad, PhD, Director of Research
• Gen1E Lifesciences, Inc. – Ritu Lal, PhD, MS, Co-Founder and CEO
• Globin Solutions, Inc. – Jason Rose, MD, MBA, President & CEO
• Vasomune Therapeutics, Inc. – Harold Kim, PhD, Vice President, Research and Scientific Affairs

Pioneer Sponsor Address

• Primal Kaur, MD, MBA, VP, Global Development, Amgen

Panel: Business Development

• Moderators: Sarah Spencer (EcoR1)
• Jeannie Rojas, PhD, MBA - Sr. Director, Transactions, Worldwide Business Development, GSK
• Mark Dowling, PhD - Head of External Innovation - Immunology, Sanofi
• Ajay Narasima, PhD - Head of Business Development, Immunology, Infectious Disease and Cardiometabolism, Genentech

Showcase Four: Technology Innovators: Devices, Digital, AI and More

• Albus Health - Mikesh Udani, MSc, Founder and CEO
• CSA Medical – Wendelin Maners, President and CEO
• DevPro Biopharma – Colin Reisner, MD, ATSF – Founder and CEO
• myBiometry – Bryan Nolan, Founder and CEO
• Synapse Biomedical – Raymond Onders, MD, Founder
• VisionHealth GMBH – Sabine Haeussermann, PhD, Founder and CEO

Showcase Five: Fibrosis Innovators

• Fibronox – Louise Hecker, PhD, Chief Science Officer
• Halo Biosciences, Inc. – Anissa Kalinowski, MBA, MSc, Co-Founder and CEO
• Haya Therapeutics – Heather Lynn, PhD, Project Scientist
• Tianali Biotech, LTD – Alistair G. Stewart, PhD, Chief Science Officer

RIS Featured Success Stories

• Moderator: David Morris, MD – President, Therapeutics and Technology, Valo Health
• Roberto Bellini, Managing Director BSQUARED Capital

Panel: Revisiting the Pumonary Functions Test

• Moderator: Craig Conoscenti, MD, ATSF - Avalyn Pharma, Inc.
• Amy Olson, MD, MSPH – Executive Director, Medical Affairs Strategy Team Lead, Boehringer Ingelheim Pharmaceuticals, Inc.
• Toby Maher, MBBS, MSC, PhD – Professor of Clinical Medicine, Keck School of Medicine, University of Southern California
• Helen Venn – Strategic Projects Director, Vitalograph
• Todd Austin – Executive Vice President, Global Business Development and Strategy, MGC Diagnostics

Closing Remarks and Sponsor Recognition

• Sarah Spencer (EcoR1) and Tim Watkins (Gilead Sciences)